| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/21/2004 | WO2002102306A8 Methods and compositions for inhibiting, preventing, or reducing tumor cell growth in patients resistant to the antineoplastic effects of antiestrogen therapy |
| 05/21/2004 | WO2002063025A8 Muscle-directed gene therapy with aav-1 and aav-6 vectors |
| 05/21/2004 | WO2002058724A8 Use of lp82 to treat body weight disorders |
| 05/21/2004 | WO2002040674A9 '67118', '67067' and '62092', human proteins and methods of use thereof |
| 05/21/2004 | WO2000066068A3 Method for inducing growth and enhancing survival of nervous tissue |
| 05/21/2004 | WO2000058340A3 50 human secreted proteins |
| 05/21/2004 | WO2000032745A3 Homologous 28-kilodalton immunodominant protein genes of ehrlichia canis and uses thereof |
| 05/21/2004 | CA2504915A1 Allele-specific rna interference |
| 05/21/2004 | CA2504694A1 Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 05/21/2004 | CA2504350A1 Apkc isoforms in nervous system disorders and cancer |
| 05/21/2004 | CA2501523A1 Human type ii diabetes gene-kv channel-interacting protein (kchip1) located on chromosome 5 |
| 05/20/2004 | US20040097705 Small acid-soluble spore protein and uses thereof |
| 05/20/2004 | US20040097659 Polyethylene glycol containing sugar residue and carboxylic acid side chains; drug delivery and gene transfer carrier; aggregation inhibition; expression efficiency; water solubility |
| 05/20/2004 | US20040097458 Providing microprojectiles carrying polynucleic acid sequences; accelerating the microprojectiles at the preselected-cells, with the microprojectiles contacting cells to penetrate vertebrate cells and deposit polynucleic acid |
| 05/20/2004 | US20040097457 Protein disulfide isomerase and abc transporter homologous proteins involved in the regulation of energy homeostasis |
| 05/20/2004 | US20040097456 Using a cytokine for prophylaxis, therapy and diagnosis of skin related growth disorders in mammals |
| 05/20/2004 | US20040097455 Cloning of reporter genes and cDNA encoding for therapeutic proteins for the treatment of hepatic, pulmonary, renal, heart, pancreas fibrosis, keloids and hypertrophic scars, in mammals, including human beings |
| 05/20/2004 | US20040097454 Method for modulation of cell phenotype |
| 05/20/2004 | US20040097453 Introducing to the subject, or to a target group of cells from the subject, an expressible polynucleotide encoding a eukaryotic heat shock protein for stimulating a therapeutic immune response |
| 05/20/2004 | US20040097452 Modulation of kallikrein 6 expression |
| 05/20/2004 | US20040097443 Modulation of jerky-like 1 expression |
| 05/20/2004 | US20040097442 For prophylaxis and therapy of cancer |
| 05/20/2004 | US20040097441 Modulation of NIMA-related kinase 6 expression |
| 05/20/2004 | US20040097440 Modulation of jumonji expression |
| 05/20/2004 | US20040097414 Genetic engineered Dna; gene therapy |
| 05/20/2004 | US20040096939 Modifier of organelle metabolism |
| 05/20/2004 | US20040096889 Compositions, organisms and methodologies employing a novel human kinase |
| 05/20/2004 | US20040096888 Comprises nucleotide sequences coding cyclin dependent kinase (PELOTA) for diagnosis, treatment, prognosis and prevention of cell proliferative, cardoivascular, inflammatory, arthritic disorders |
| 05/20/2004 | US20040096881 For prophylactics/diagnostics/therapeutics; endothelial nitric oxide synthase (eNOS) |
| 05/20/2004 | US20040096877 For diagnosis/treatment/prevention of inflammation/asthma/ allergies |
| 05/20/2004 | US20040096868 For diagnosis/treatment of cancer; drugs; kits; cell-free analysis; solid phase synthesis |
| 05/20/2004 | US20040096848 Oligomeric compounds for the modulation HIF-1alpha expression |
| 05/20/2004 | US20040096847 Regulation of human secretin receptor-like gpcr |
| 05/20/2004 | US20040096843 Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules |
| 05/20/2004 | US20040096835 Modulation of TNFSF14 expression |
| 05/20/2004 | US20040096834 Modulation of HIP-1 protein interactor expression |
| 05/20/2004 | US20040096833 Modulation of FBP-interacting repressor expression |
| 05/20/2004 | US20040096467 Drug, in particular for modulating the immunological response for the control of viruses, tumors, bacteria and parasites |
| 05/20/2004 | US20040096459 Polypeptides to be administered especially to humans and in particular for therapeutic use. The polypeptide to elicit an immune response upon administration to the human subject. |
| 05/20/2004 | US20040096435 Methods for screening compounds that modulate lipid metabolism |
| 05/20/2004 | US20040096433 Alleviating hypertension associated with fetal malnutrition in utero, resulting in a post-natal condition known as fetal programming. Factors that lead to fetal programming can be used to predict development of conditions associated with |
| 05/20/2004 | US20040096426 Compositions and methods for identifying antigens which elicit an immune response |
| 05/20/2004 | US20040096425 Method for introducing a molecule into the cytosol of a cell in which the cell is contacted with a photosensitising agent, the cell is irradiated with light of a wavelength effective to activate the photosensitising agent and, substantially at the |
| 05/20/2004 | US20040096403 Method for drug delivery to the pulmonary system |
| 05/19/2004 | EP1420065A1 Process for producing inactivated virus envelope |
| 05/19/2004 | EP1419260A2 Recombinant vector derived from adeno-associated virus for gene therapy |
| 05/19/2004 | EP1419257A1 Methylation resistant vectors |
| 05/19/2004 | EP1419256A2 Conjugates for the modulation of immune responses |
| 05/19/2004 | EP1419245A2 Pseudotyped adeno-associated viruses and uses thereof |
| 05/19/2004 | EP1419244A2 Electrodes coated with treating agent and uses thereof |
| 05/19/2004 | EP1419241A2 Improved nitroreductase enzymes |
| 05/19/2004 | EP1419168A2 Antisense modulation of apolipoprotein b expression |
| 05/19/2004 | EP1418949A2 Inhibitor of dna methylation |
| 05/19/2004 | EP1418948A1 Replicating adenovirus vectors |
| 05/19/2004 | EP1418941A2 Vaccination against the feline immunodeficiency virus |
| 05/19/2004 | EP1418940A2 Dna expression vectors and methods of use |
| 05/19/2004 | EP1418937A2 Enhancing organ maturity in neonates and predicting their duration of intensive care |
| 05/19/2004 | EP1418936A2 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio. |
| 05/19/2004 | EP1418931A1 New drug |
| 05/19/2004 | EP1418814A2 Production of transduced hematopoietic progenitor cells |
| 05/19/2004 | EP1418810A1 Oral treatment of hemophilia |
| 05/19/2004 | EP1234024B1 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 05/19/2004 | EP1021553B1 Eukaryotic gene expression cassette and uses thereof |
| 05/19/2004 | EP1017810B1 Agonist and antagonist peptides of carcinoembryonic antigen (cea) |
| 05/19/2004 | EP1011734B1 Gene therapy vehicle comprising dermal sheath tissue |
| 05/19/2004 | EP0960123A4 Sprouty protein and coding sequence |
| 05/19/2004 | EP0834560B1 Fine magnetic particles containing useful proteins bound thereto, process for producing the same, and use thereof |
| 05/19/2004 | EP0832253B1 Nucleic acid respiratory syncytial virus vaccines |
| 05/19/2004 | EP0787190B1 Hepatitis e virus antigens and uses therefor |
| 05/19/2004 | EP0637237B1 Calcium receptor-active molecules |
| 05/19/2004 | CN1498271A Potassium channel interactors protein and uses therefor |
| 05/19/2004 | CN1498115A Hydroxyalkyl starch-active agent-conjugate |
| 05/19/2004 | CN1150035C Recombination plasmid and application in disease prevention and control |
| 05/18/2004 | US6737523 For treatment of various forms of cancer |
| 05/18/2004 | US6737520 For use as substrate for ribonuclease and controlling binding affinity/nuclease resistance |
| 05/18/2004 | US6737507 Antiangiogenic peptides and compositions thereof |
| 05/18/2004 | US6737413 SOX-9 gene and protein and use in the regeneration of bone or cartilage |
| 05/18/2004 | US6737412 Antisense oligodeoxynucleotides regulating expression of TNF α |
| 05/18/2004 | US6737251 Nucleotide and deduced amino acid sequences of tumor gene Int6 |
| 05/18/2004 | US6737232 IAPs associated cell cycle proteins, compositions and methods of use |
| 05/18/2004 | US6737062 Immunogenic compositions |
| 05/18/2004 | US6737054 Myocardial grafts and cellular compositions useful for same |
| 05/18/2004 | US6737052 Induction of programmed cell death by N5 gene |
| 05/18/2004 | CA2343719C New human hepatoma-derived growth factor encoding sequence and polypeptide encoded by such dna sequence and producing method thereof |
| 05/13/2004 | WO2004039989A1 Method of expressing protein having unnatural amino acid integrated thereinto |
| 05/13/2004 | WO2004039413A1 Immune stimulating and controlling composition comprising bacterial chromosomal dna fragments and non-toxic lipopolysaccharides |
| 05/13/2004 | WO2004039397A1 Use of alpha 1-antichymotrypsin polypeptides, or nucleic acids encoding them, in combination with alpha 1-antitrypsin polypeptides, or nucleic acids encoding them, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds |
| 05/13/2004 | WO2004022102A3 Pharmaceutical formulation with non-steroidal antiphlogistic agents and nucleic acids for the internalization of nucleic acids into eucaryotic cells |
| 05/13/2004 | WO2004019036A3 Method for identifying substances |
| 05/13/2004 | WO2004014302A3 Mechanisms of myoblast transfer in treating heart failure |
| 05/13/2004 | WO2004009792A3 Transposon-based vectors and methods of nucleic acid integration |
| 05/13/2004 | WO2003105778A3 Phosphatidylinositol-4-phosphate 5-kinase, type ii beta inhibitors for inhibiting angiogenesis |
| 05/13/2004 | WO2003099781A3 METHODS FOR THE IDENTIFICATION OF IKKα FUNCTION AND OTHER GENES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES |
| 05/13/2004 | WO2003057892B1 Viruses with enhanced lytic potency |
| 05/13/2004 | WO2003051454A3 Methods for particle-assisted polynucleotide immunization using a pulsed electric field |
| 05/13/2004 | WO2003050245A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 05/13/2004 | WO2003049762A3 Immunisation against chlamydia trachomatis |
| 05/13/2004 | WO2003045420A3 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization |
| 05/13/2004 | WO2003039475A8 Methods of identifying and using modulators of fractalkine receptor |
| 05/13/2004 | WO2003034903B1 Psma antibodies and protein multimers |